Mohamed S Nafie

101PUBLICATIONS
167CO-AUTHORS
Molecular targetsHaematological tumoursCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (101)

|Sep 25, 2026
Bridging BET bromodomain and immune checkpoint inhibitors through generative bioorganic frameworks for next-generation cancer immunotherapy.

|Sep 24, 2026
ATP is not always pro-inflammatory: rethinking purinergic signalling in cancer and autoimmunity.

|Jul 17, 2026
Thiazole-Derived Dual EGFR/CDK-2 Inhibitors: Rational Design, Synthesis, In Vitro Anticancer Evaluation, Mechanistic Profiling, and Computational Binding Analysis.

|Jul 16, 2026
Recent Overview on the Molecular Hybrids Integrated With Benzosuberone/Benzo[7]annulene Derivatives as Multi-Target Therapeutics.

|Jul 08, 2026
Structure-Based Design, Synthesis, and Biological Evaluation of Oxadiazole-Morpholine Hybrids as Potent PARP-1 Inhibitors Inducing Apoptosis in Breast Cancer Cells.

|Jun 15, 2026
Triazole-Sulfonamide Hybrids as Carbonic Anhydrase Inhibitors: Emerging Chemistry and Bioactivity Insights From 2020 to 2025.

Pageof 17

Frequent Collaborators

13 joint publications

Mohamed Khaled Diab

12 joint publications

Sameh S Elhady

11 joint publications

Sherif Ashraf Fahmy

10 joint publications

Assem Barakat